Glucotrack Files DEF 14A on Executive Compensation
Ticker: GCTK · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1506983
Sentiment: neutral
Topics: executive-compensation, stock-awards, proxy-statement
Related Tickers: GCTK
TL;DR
Glucotrack's 2025 DEF 14A is out, showing exec comp & stock award values for 2024.
AI Summary
Glucotrack, Inc. filed a DEF 14A on April 28, 2025, detailing executive compensation and stock awards for the fiscal year ending December 31, 2024. The filing includes information on the fair value of stock options and awards granted and outstanding for the fiscal years 2022, 2023, and 2024.
Why It Matters
This filing provides transparency into how Glucotrack compensates its top executives and the value of equity awards, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not inherently present new financial risks.
Key Numbers
- 2024 — Fiscal Year (Reporting period for executive compensation and stock awards.)
- 2023 — Fiscal Year (Comparative reporting period for executive compensation and stock awards.)
- 2022 — Fiscal Year (Comparative reporting period for executive compensation and stock awards.)
Key Players & Entities
- Glucotrack, Inc. (company) — Filer
- 0001641172-25-006348 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20241231 (date) — Fiscal Year End
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide information regarding the solicitation of proxies for the company's annual meeting of stockholders, including details on executive compensation and corporate governance.
What specific financial data related to compensation is detailed in the filing?
The filing details the fair value of option awards and stock awards granted and outstanding for the fiscal years 2022, 2023, and 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 28, 2025.
What is Glucotrack, Inc.'s fiscal year end date?
Glucotrack, Inc.'s fiscal year end date is December 31.
What is the company's SIC code and industry classification?
The company's SIC code is 3841, classified under SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Glucotrack, Inc. (GCTK).